Pfizer says its vaccine showed promising results in early studies, with 82% efficacy in preventing severe sickness during the first 90 days of life and 69% efficacy through the first six months.
READ MORE: https://gma.abc/3fkXBkn
#ABCNews #pfizer #rsv #vaccine
